Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 5:3:127.
doi: 10.3389/fphar.2012.00127. eCollection 2012.

Brain-Gut Interactions in IBS

Affiliations

Brain-Gut Interactions in IBS

Jakub Fichna et al. Front Pharmacol. .

Abstract

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with an estimated prevalence of 10-20%. Current understanding of the pathophysiology of IBS is incomplete due to the lack of a clearly identified pathological abnormality and due to the lack of reliable biomarkers. Possible mechanisms believed to contribute to IBS development and IBS like symptoms include physical stressors, such as infection or inflammation, psychological, and environmental factors, like anxiety, depression, and significant negative life events. Some of these mechanisms may involve the brain-gut axis (BGA). In this article we review the current knowledge on the possible involvement of the BGA in IBS and discuss new directions for potential future therapies of IBS.

Keywords: autonomic nervous system; brain-gut axis; hypothalamo-pituitary-adrenal axis; irritable bowel syndrome; pathophysiology.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Adeyemo M. A., Spiegel B. M., Chang L. (2010). Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment. Pharmacol. Ther. 32, 738–75510.1111/j.1365-2036.2010.04409.x - DOI - PMC - PubMed
    1. Aguilera G., Subburaju S., Young S., Chen J. (2008). The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress. Prog. Brain Res. 170, 29–3910.1016/S0079-6123(08)00403-2 - DOI - PMC - PubMed
    1. Akira S., Takeda K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–51110.1038/nri1391 - DOI - PubMed
    1. Arborelius L., Owens M. J., Plotsky P. M., Nemeroff C. B. (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160, 1–1210.1677/joe.0.160R001 - DOI - PubMed
    1. Arebi N., Gurmany S., Bullas D., Hobson A., Stagg A., Kamm M. (2008). Review article: the psychoneuroimmunology of irritable bowel syndrome – an exploration of interactions between psychological, neurological and immunological observations. Aliment. Pharmacol. Ther. 28, 830–84010.1111/j.1365-2036.2008.03801.x - DOI - PubMed